Services

We help companies develop market access strategies and plans. We focus on defining the market access ambitions, and how the strategy should be constructed in terms of pricing and reimbursement potentials, and target patient population. Furthermore, we assess the main challenges in the market, requirements from decision-makers and what it takes to meet these requirements and challenges.

We help companies prepare a market access plan for key activities and tactics before a launch. The typical elements of a plan are: a stakeholder analysis and engagement plan, assessment of the need for evidence to accommodate market access challenges, preparation of value communication tools and payer materials as well as preparation of the dialogue with authorities.

We help companies map the market access landscape for specific illnesses. This mapping can be used to facilitate the market access strategy and planning.

The needs and demands for the analysis are developed in close collaboration between Incentive and the client. We typically analyse the landscape by investigating what the unmet needs are for the patients. How well are the patients treated with the current treatment options and what treatment guidelines exist? We investigate the competitive environment focusing on both current and future treatment options, and also how current treatments are priced and to which extent reimbursed. We look into the pricing and reimbursement processes and the timelines for market access.

Incentive helps affiliates improve their dialogue with the Medicines Council, Amgros and the Danish Reimbursement Committee, e.g. via cost analyses and examinations of clinical documentation. The cost analyses are carried out in accordance with Amgros’ guidelines for cost analyses and the Danish Medicines Agency’s instructions for carrying out health-economic analyses.

In addition to these analyses, which are targeted at the authorities, we also conduct other cost analyses, which our clients use more widely in their communication with relevant stakeholders.

We develop different types of economic models to measure costs, cost-effectiveness and cost-utility, e.g. cost-effectiveness and budget impact models, or we help clients who have existing models with using and adjusting their models. In this way, our work enables our clients to document the effect and value of their products. Furthermore, we assist with conducting health technology assessments (HTAs), and, in a Danish context, mini HTAs. We also facilitate applications and dialogue between authorities and clients in several countries.

Incentive conducts surveys of patients and the public within a range of disease areas. Using the results, we map out quality-of-life ratings, preferences, and willingness and ability to pay.

We analyse patient-reported outcomes (PRO) and patients’ expected quality of life, which is useful information to have when in dialogue with authorities regarding value creation in relation to the price of medicine. The results of many of our projects have been published in scientific journals.

We use registers or databases to explore the use of healthcare services and prescription medicine as well as to retrieve data on employment, benefits and education. We undertake burden of illness and cost of illness studies to estimate the societal costs of different diseases and treatment options. For instance, we analyse patient/disease prevalence and incidence, age and gender distributions, co-morbidities, risk factors and mortality.

We take our research even further, documenting treatment patterns for different diseases by analysing e.g. development of any use over a length of time and doses in different stages. All analyses aim to improve the understanding of patients’ burden of illness as they navigate the Danish healthcare system.

We work with clients to publish evidence based on outcomes from e.g. register-based studies, health-economic models, surveys, patient-reported outcomes and literature reviews.

We have helped many companies with communicating complex results and messages in a clear way. We have solid experience in writing manuscripts for publication in peer-reviewed journals. We can also assist in preparing abstracts and posters for scientific conferences.

We provide overviews of the published literature within a disease area, e.g. for a product and relevant comparators to illustrate the burden of illness for a specific disease. The documentation can, among other things, be used for determining a product’s clinical effect and cost-effectiveness and for identifying and generating input data for economic analyses.